Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 68

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 68
---
 broader environmental liabilities. Noncompliance or accidents could result in significant fines, penalties, or liabilities exceeding our resources, and compliance with evolving regulations may increase our operational costs and impact our business activities.

| 37 |

Our business activities may be subject to the U.S. Foreign Corrupt Practices Act and similar anti-bribery and anti-corruption laws of other countries in which we operate, as well as U.S. and certain foreign export controls, trade sanctions, and import laws and regulations. Compliance with these legal requirements could limit our ability to compete in foreign markets and subject us to liability if we violate them.

Our global business is subject to the U.S. Foreign Corrupt Practices Act (FCPA), domestic bribery laws, the U.S. Travel Act, and similar anti-bribery and anti-corruption laws in other countries. These laws prohibit improper payments or benefits to public or private sector officials to obtain or retain business, and hold us liable for the actions of employees, agents, and third parties—even without our direct knowledge or approval. As we expand internationally, our exposure to these risks increases, especially since many healthcare professionals abroad are considered foreign officials under the FCPA.

We must also maintain accurate records and effective compliance controls. Any violations—by us or our partners—could lead to investigations, fines, severe civil or criminal penalties, reputational harm, loss of export privileges, and restrictions on our ability to do business in certain countries. Additionally, our products are subject to U.S. and foreign export controls, sanctions, and import laws. Noncompliance or new regulatory restrictions could delay or prevent product exports, reduce international sales, and negatively impact our business and financial results.

Risks Related to Employee Matters, Managing Our Growth and Other Risks Related to Our Business

Our success is highly dependent on our ability to attract and retain highly skilled executive officers and employees.

To succeed, we must recruit, retain, manage and motivate qualified clinical, scientific, technical and management personnel, and we face significant competition for experienced personnel. We are highly dependent on the principal members of our management and scientific and medical staff, particularly Marshall Hayward, our Co-Founder and Chief Scientific Officer. If we do not succeed in attracting and retaining qualified personnel, particularly at the management level, it could adversely affect our ability to execute our business plan and harm our operating results. In particular, the loss of one or more of our executive officers could be detrimental to us if we cannot recruit suitable replacements in a timely manner. We do not maintain “key person” insurance